top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cancer Immunology
Cancer Immunology
Autore Subramanian Subree
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (316 p.)
Soggetto topico Medicine
Soggetto non controllato adaptive immunity
anti-CD20 antibody
anti-CTLA-4
anti-PD-1
antibody-dependent cellular cytotoxicity (ADCC)
antigen presenting cells
antigen-presenting cells
Atypical Chemokine Receptor 4 (ACKR4)
B cell aplasia
BAP1
BiFab
bispecific antibody
cancer
cancer stem cells (CSCs)
cancer vaccine
CAR T
carcinoma
CD19-CAR-T
CD28
cell therapy
chemo-enzymatic approach
chemotherapy
classical and endemic Kaposi Sarcoma
colon cancer
colorectal cancer
combination immunotherapy
CTLA-4
cytotoxicity
dendritic cells
differentiation
DNA methylation
epidemiologic studies
Fab
IDO inhibitor
IFN-γ
IL-7
IL15
immune checkpoint blockade
immune checkpoint inhibitors
immune checkpoints
immune evasion
immunomodulation
immunosuppression
immunotherapy
indoleamine 2,3 dioxygenase 1
inhibitory CAR
innate immunity
interferon
KIR
kynurenine pathway
m6A
melanoma
MICA/B mAb
multi-state modelling
n/a
NK cells
NKG2D
organ transplantation
osteoclasts
PD-1
PD-L1
primary liver cancer
prostate cancer
resistance
RNA methylation
S-adenosylmethionine (SAM)
sortase A
systemic treatment
T cells
T-cell priming
TCR diversity
TIL
treatment free interval
Treg cells
triple negative breast cancer
tryptophan 2,3 dioxygenase 2
tumor microenvironment
tumor-infiltrating lymphocytes
uveal
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557349203321
Subramanian Subree  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
Autore Ylostalo Joni H
Descrizione fisica 1 online resource (204 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato 3-methyladenine
3D culture
adipose tissue-derived stem cells (ASCs)
adipose-derived stem cell
AKB-6548
angiogenesis
astrocytes
autophagy
axon growth
CD206
cell therapy
chemotaxis
combination therapy
engineered cardiac patches
exosome
fibroblast growth factor 2
hepatocyte growth factor
hypoxia
IFN-γ
immunomodulation
immunosuppression
iMSC secretome
inflammation
iPSC-derived MSCs
liver cirrhosis
macrophages
malignant pleural mesothelioma (MPM)
mesenchymal stem cells
mesenchymal stromal cells
mesothelioma
nanofiber-hydrogel composite
neural
neuroprotection
neurospheres
osteogenic differentiation
oxygen conditions
paracrine potential
phagocytosis
placenta-derived mesenchymal stem cells
pluripotency
polyunsaturated fatty acid
potentiation of iMSC efficacy
pre-conditioning
preconditioning
priming
quiescence
rapamycin
secondary injury
secretome
secretory profile
spheroids
spinal cord injury
umbilical cord
Vadadustat
Wharton's jelly mesenchymal stem cells
WKYMVm
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Enhancing Mesenchymal Stem Cells
Record Nr. UNINA-9910595079403321
Ylostalo Joni H  
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Systemic Autoinflammatory Diseases-Clinical Rheumatic Challenges
Systemic Autoinflammatory Diseases-Clinical Rheumatic Challenges
Autore Feist Eugen
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (266 p.)
Soggetto topico Medicine
Soggetto non controllato adult-onset Still's disease
anakinra
anti-IL-1 treatment
arthritis
ASAS classification criteria
aspiration
autoimmune
autoinflammation
autoinflammatory disease
autoinflammatory diseases
autoinflammatory disorder
canakinumab
CAPS
CINCA
clinical management
colchicine
computed tomography (CT)
coronavirus
cytokines
damage index
diagnostic delay
DNA damage repair
dysphagia
edema
FCAS
febuxostat
FMF
genetic inheritance
gout
haemophagocytic lymphohistiocytosis
hearing loss
hepatotoxicity
Hounsfield unit
human leukocyte antigen
IFN-γ
IL-1 inhibitors
imaging
immunoglobulin G4-related orbital disease (IgG4-ROD)
inflammation
inflammatory idiopathic myopathy
Interleukin-1
JAK inhibitor
macrophage activation syndrome
monogenic autoinflammatory syndrome
MWS
myositis
n/a
neoplasms
new genetic variant
NGS
NOMID
orbital lymphoma (OL)
PBMCs
personalized therapy
pneumonia
proliferation
prophylaxis
proteasome
proteasome-associated autoinflammatory syndrome
rheumatoid arthritis
SARS-CoV-2 antibody response
spondyloarthritis
SURF
synovitis
systemic-onset juvenile idiopathic arthritis
T lymphocytes
therapy
undifferentiated enthesitis and/or arthritis
urticarial-like rash
γH2AX
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557349503321
Feist Eugen  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui